Other
Mechanically Ventilated Patients
0
Pipeline Programs↗
2
Active Trials↗
3
Companies Involved↗
Mechanically Ventilated Patients is an early-stage landscape with 0 programs across 3 companies. The most active players are Novartis, Sanofi, Cardeas Pharma.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
19
clinical trials
Completed7 · 37%
Unknown status6 · 32%
Withdrawn3 · 16%
Not yet recruiting1 · 5%
Terminated1 · 5%
Recruiting1 · 5%
Clinical Trials
Trial Activity
19 trials
Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD
Completed·—·Phase 4·NCT03333395·60 enrolled
Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients
Completed·—·Phase 2·NCT02916433·5 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)